These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1372593)

  • 1. Antibodies to hepatitis C virus in blood donors.
    Sood G; Chauhan A; Sehgal S; Agnihotri S; Dilawari JB
    Indian J Gastroenterol; 1992 Jan; 11(1):44. PubMed ID: 1372593
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus in patients with acute and chronic liver disease.
    Mehta SK; Singh V; Bhasin DK; Kumar YR; Kochhar R
    Indian J Gastroenterol; 1992 Jul; 11(3):146. PubMed ID: 1380490
    [No Abstract]   [Full Text] [Related]  

  • 3. HCV infection in a north Indian hospital.
    Narang A; Kar P; Chakravarty A
    Indian J Gastroenterol; 1993 Oct; 12(4):156. PubMed ID: 7505771
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-transfusion hepatitis C virus infection.
    Kleinman S; Busch M; Holland P
    N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. Trent Regional Hepatitis C Virus Study Group.
    Irving WL; Neal KR; Underwood JC; Simmonds PN; James V
    BMJ; 1994 Mar; 308(6930):695-6. PubMed ID: 8142794
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum antibodies to hepatitis C virus: analysis of risk factors of seropositivity in a population of blood donors in metropolitan France].
    Maisonneuve P; Aymard JP; Lemaire JM; Baillet A; Janot C
    Rev Med Interne; 1991; 12(6):416-8. PubMed ID: 1724323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low rate of hepatitis C virus antibodies in blood donors and pregnant women from Niger.
    Develoux M; Meynard D; Delaporte E
    Trans R Soc Trop Med Hyg; 1992; 86(5):553. PubMed ID: 1282279
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C virus and organ donor cards.
    Rouse A; Goodrick MJ; Anderson NA; Fraser ID; Pearson V
    BMJ; 1992 Feb; 304(6825):502. PubMed ID: 1372193
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epidemiologic study of anti-HCV antibodies in Tunisian blood donors].
    Slama H; Mojaat N; Dahri R; Boukef K
    Rev Fr Transfus Hemobiol; 1991 Dec; 34(6):459-64. PubMed ID: 1663358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of seroepidemiology of hepatitis C in blood donors between Bangladesh and Japan.
    Khan M; Husain M; Yano M; Hashizume K; Yousuf M; Tanaka E; Matsumoto A; Furuta S; Kiyosawa K
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():28-31. PubMed ID: 7689505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus antibody in acute and chronic liver diseases in India.
    Gupta H; Irshad M; Joshi YK; Acharya SK; Tandon BN
    Scand J Infect Dis; 1990; 22(5):627. PubMed ID: 2175450
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serological study on hepatitis C (HCV) in 4371 blood donors].
    Arnone M; Pinducciu G; Usai M; Pitzus F; Pintus L
    Ann Ig; 1990; 2(5):353-8. PubMed ID: 1715726
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies to hepatitis C virus and surrogate marker testing of blood donors to prevent non-A, non-B hepatitis.
    Kakaiya R; Stephans J; Carnahan G; Ahmed P; Miller WV
    Transfusion; 1991 Oct; 31(8):780-1. PubMed ID: 1656555
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies to hepatitis C virus in people from Yucatan, Mexico.
    Góngora-Biachi RA; González-Martínez P; Puerto FI; Yamaguchi K; Nishimura Y; Takatsuki K
    Rev Invest Clin; 1992; 44(2):284. PubMed ID: 1332170
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].
    Janot C
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):347-50. PubMed ID: 2177596
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of screening and complementary tests for anti-HCV antibodies].
    Głoskowska-Moraczewska Z; Kacperska E; Seyfried H
    Acta Haematol Pol; 1993; 24(3):273-80. PubMed ID: 7504386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus antibody in Poland.
    Laskus T; Radkowski M; Lupa E; Cianciara J; Slusarczyk J; Halama G; Horban A
    Scand J Infect Dis; 1991; 23(3):385-6. PubMed ID: 1715607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiological and clinical significance of HCV antibody--future problems].
    Nishioka K
    Nihon Rinsho; 1991 Feb; 49(2):267-72. PubMed ID: 1849181
    [No Abstract]   [Full Text] [Related]  

  • 20. [Seroprevalence of hepatitis C antiviral antibodies in blood donors in N'Djamena (Chad)].
    Massenet D; Djime O
    Bull Soc Pathol Exot; 1993; 86(4):235. PubMed ID: 7507370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.